Risk-Based Optimization or Forecasting? The Impact On Clinical Trial Supply Planning

Life Sciences, Clinical Trials, Pharma Manufacturing & Supply Chain,
  • Monday, December 07, 2020

Clinical trial optimization and clinical trial forecasting are often confused with one another, but mixing up the two approaches can bring dangerous results when managing a clinical supply chain. Clinical trial optimization that is risk-based delivers many benefits including ensuring 100% patient service levels and more efficient planning. It also brings information for fact-based decision making to the table in comparison with clinical supply forecasting tools. In order to bring real efficiency while keeping patients safe, the only answer is risk-based optimization.



Amaury Jeandrain, Head of Life Sciences Solutions Adoption, N-SIDE

Amaury Jeandrain is an expert in Clinical trial supply and manufacturing optimization. He started his career in clinical supply chain working for a CMO before joining N-SIDE. In his 5 years of experience at N-SIDE, Amaury supported the optimization of hundreds of trials and programs from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the Adoption of N-SIDE’s solutions.

Message Presenter

Cyrille Lefèvre, Senior Expert, N-SIDE

Cyrille Lefèvre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 8 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Cyrille also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.

Message Presenter

Who Should Attend?

  • Clinical Supply
  • Clinical Operations
  • Clinical Outsourcing
  • Program Management
  • Clinical Supply Planning

What You Will Learn

  • To identify the differences between risk-based optimization and forecasting for clinical supply chain and manufacturing planning, and how to recognise them
  • How clinical trial optimization can reduce drug waste & budgets, while achieving 100% service level and accelerated timelines
  • See real-life case studies demonstrating the impact of risk-based optimization vs. forecasting

Xtalks Partner


N-SIDE, an innovative software consulting company, has been an active player in clinical trial supply chain management for almost 20 years. Using cloud-based cutting-edge technologies, their solutions optimize the entire clinical trial supply chain management process from planning and production through to protocol design and delivery of supplies. The N-SIDE Suite for Clinical Trials enables the pharmaceutical and biotech industry to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account